Hosted on MSN
DYAI: One Strain To Rule Them All
Dyadic Applied BioSolutions, Inc. (NASDAQ:DYAI) announced second quarter 2025 results and held its first conference call under its new name. As we look ahead to the remainder of 2025, we expect ...
Mammalian cells, both in vivo and in vitro, require iron for cell growth, DNA replication, cellular respiration, and metabolism. Transferrin is the natural physiological method by which iron is ...
JUPITER, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions ("Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results